Pharma Journalist - Page 72 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Illumina & Ovation.io Launch Novel GLP-1 Dataset for Faster Therapy Development

FDA Approves Johnson & Johnson’s IMAAVY for Broad Generalized Myasthenia Gravis Population

Creyon Bio and Lilly Partner on RNA-Targeted Oligo Therapy

QIAGEN Expands Digital PCR Portfolio with New Lentivirus Solutions

FDA Approves RINVOQ for Giant Cell Arteritis

Oxford, Boehringer, Cumulus Launch First-Ever Study on Daily Life with Psychiatric Disorders

FDA Approves ZEVASKYN, First Cell-Based Gene Therapy for RDEB

Merck Breaks Ground on $1B Biologics Center in Delaware

Prilenia Partners with Ferrer for Pridopidine in Europe and Beyond

Biohaven Secures Up to $600M Investment from Oberland Capital